Ceragenix Completes Patient Visit Phase of Clinical Trial Study to Compare Efficacy of EpiCeram(R) to Elidel(R).
Business Wire › March 13, 2008
Linked as:
Extract
Ceragenix Completes Patient Visit Phase of Clinical Trial Study to Compare Efficacy of EpiCeram(R) to Elidel(R).
DENVER -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that it had completed the patient visit phase of its previously a...
See the full content of this document
Sponsored links
